Abstract
Glucocerebrosidase is the enzyme that is deficient in Gaucher diseases. Four monoclonal antibodies reacting with at least two different epitopes of this enzyme have been produced. The amounts of glucocerebrosidase in fibroblasts of patients with all three types of Gaucher disease were investigated by radioiodinating two of the antibodies and measuring their binding to fibroblast extracts immobilized on nitrocellulose filters. The amount of glucocerebrosidase antigen was decreased in all cases of Gaucher disease, particularly in the fibroblasts of patients with the more severe neuronopathic forms of the disorder, types II and III. The catalytic activity was reduced to a greater extent than the amount of antigen in all cases, so that the specific activity of the residual enzyme was found to be diminished. Although measurements in individual cases were quite reproducible and the amount of antigen detected by monoclonal antibodies reacting with different epitopes was quite similar, there was considerable variation between patients. This finding is consistent with the apparent within-type genetic heterogeneity of Gaucher disease, even within the Ashkenazi Jewish population in which it is most prevalent.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barneveld R. A., Tegelaers F. P., Ginns E. I., Visser P., Laanen E. A., Brady R. O., Galjaard H., Barranger J. A., Reuser A. J., Tager J. M. Monoclonal antibodies against human beta-glucocerebrosidase. Eur J Biochem. 1983 Aug 15;134(3):585–589. doi: 10.1111/j.1432-1033.1983.tb07606.x. [DOI] [PubMed] [Google Scholar]
- Beutler E. Gaucher's disease in an asymptomatic 72-year-old. JAMA. 1977 Jun 6;237(23):2529–2529. [PubMed] [Google Scholar]
- Dale G. L., Villacorte D. G., Beutler E. Solubilization of glucocerebrosidase from human placenta and demonstration of a phospholipid requirement for its catalytic activity. Biochem Biophys Res Commun. 1976 Aug 23;71(4):1048–1053. doi: 10.1016/0006-291x(76)90760-9. [DOI] [PubMed] [Google Scholar]
- Ginns E. I., Brady R. O., Pirruccello S., Moore C., Sorrell S., Furbish F. S., Murray G. J., Tager J., Barranger J. A. Mutations of glucocerebrosidase: discrimination of neurologic and non-neurologic phenotypes of Gaucher disease. Proc Natl Acad Sci U S A. 1982 Sep;79(18):5607–5610. doi: 10.1073/pnas.79.18.5607. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ginns E. I., Tegelaers F. P., Barneveld R., Galjaard H., Reuser A. J., Brady R. O., Tager J. M., Barranger J. A. Determination of Gaucher's disease phenotypes with monoclonal antibody. Clin Chim Acta. 1983 Jul 15;131(3):283–287. doi: 10.1016/0009-8981(83)90097-9. [DOI] [PubMed] [Google Scholar]
- Gravel R. A., Leung A. Complementation analysis in Gaucher disease using single cell microassay techniques. Evidence for a single "Gaucher gene". Hum Genet. 1983;65(2):112–116. doi: 10.1007/BF00286645. [DOI] [PubMed] [Google Scholar]
- Ho M. W., O'Brien J. S. Gaucher's disease: deficiency of 'acid' -glucosidase and reconstitution of enzyme activity in vitro. Proc Natl Acad Sci U S A. 1971 Nov;68(11):2810–2813. doi: 10.1073/pnas.68.11.2810. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
- Marchalonis J. J., Cone R. E., Santer V. Enzymic iodination. A probe for accessible surface proteins of normal and neoplastic lymphocytes. Biochem J. 1971 Oct;124(5):921–927. doi: 10.1042/bj1240921. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pentchev P. G., Brady R. O., Blair H. E., Britton D. E., Sorrell S. H. Gaucher disease: isolation and comparison of normal and mutant glucocerebrosidase from human spleen tissue. Proc Natl Acad Sci U S A. 1978 Aug;75(8):3970–3973. doi: 10.1073/pnas.75.8.3970. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pentchev P. G., Neumeyer B., Svennerholm L., Groth C. G., Brady R. O. Immunological and catalytic quantitation of splenic glucocerebrosidase from the three clinical forms of Gaucher disease. Am J Hum Genet. 1983 Jul;35(4):621–628. [PMC free article] [PubMed] [Google Scholar]
- Raghavan S. S., Topol J., Kolodny E. H. Leukocyte beta-glucosidase in homozygotes and heterozygotes for Gaucher disease. Am J Hum Genet. 1980 Mar;32(2):158–173. [PMC free article] [PubMed] [Google Scholar]